Skip to content
Get BIO’s view on everything from health care to biofuels and the bioeconomy. The below articles include BIO statements, opinion, and calls to action, as well as articles and op-eds written by BIO leadership.
On August 4, U.S. lawmakers introduced two new bills in an effort to further strengthen the Vaccine Injury Compensation Program (VICP) and help the […]
House introduces bills to strengthen Vaccine Injury Compensation Program (VICP) Read More »
Photo: BIO’s Emily Wheeler (second from left) with Jean Mwale, Amputee Coalition regional ambassador and sepsis survivor (right), at the Amputee Coalition 2023 National
How amputees give voice to AMR Read More »
Voters hold a favorable opinion of biotechnology and support streamlined government regulatory processes to allow faster approval of biotech innovations in agriculture, according to
Creative individuals are spearheading imaginative approaches as biotech battles cancer, the leading cause of death worldwide. Profiles of leaders from a cancer institute and
Innovators describe biotech advances against cancer in I am BIO videos Read More »
The 340B Program has grown exponentially as hospitals take advantage of the opportunity to profit from drug discounts while the low-income and uninsured patients
BIO tells Senators the 340B program needs reforms so it helps patients Read More »
International partnerships are vital to delivering new biotech solutions for the health of people and the planet—and strong policies, both in the U.S. and
BIO Asia-Taiwan 2023 highlights importance of cross-border collaboration Read More »
In a big week for reauthorization of the Pandemic All Hazards and Preparedness Act (PAHPA), versions of the legislation were approved by a House
PAHPA legislation moves forward in Senate and House Read More »
After the Centers for Medicare & Medicaid Services (CMS) released its guidance for the Drug Price Negotiation Program (Negotiation Program) under the Inflation Reduction
BIO: New CMS guidance a ‘missed opportunity’ for future medical innovation, patients Read More »
The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) met on June 12-13, 2023, and announced the formation of
ICH announces discussion group on cell and gene therapy harmonization Read More »
On June 13, the House Energy & Commerce Health Subcommittee held a hearing, Legislative Solutions to Bolster Preparedness and Response for All Hazards and
BIO’s Phyllis Arthur testifies on need to reauthorize PAHPA, pass PASTEUR Act Read More »
